We invest in
companies
to catalyze their growth
adMare has helped build 36 companies, of which 25 are still active. These companies have attracted $2.4 billion of risk capital, have a combined value of $5.7 billion, and have created around 1,000 jobs in Canada.
Discover our companies below.
The Accelerator Companies include both current and past participants in adMare Accelerator, a testament to our impact across various stages of company development.
QThero
Description
Quthero Canada is an early stage life science company based on a technology developed at the University of Toronto. In ageing and upon injury such as myocardial infarction, the balance of cytokines is disturbed, creating a pro-inflammatory environment which hampers healing and regeneration. Quthero has a patented Q-peptide derived from Angiopoietin-1, that can help restore the balance to orchestrate healing and regeneration. In the adMare Accelerator, Quthero will focus on developing new heart failure drugs based on the Q-peptide technology.
More information
Hydrogels With Integrin-Binding Angiopoietin-1–Derived Peptide, QHREDGS, for Treatment of Acute Myocardial Infarction
Hydrogels contenant un peptide dérivé de l'angiopoïétine-1 se liant à l'intégrine, QHREDGS, pour le traitement de l'infarctus aigu du myocar (Article en anglais)
Back to list
Newsletter
Stay up to date on the
latest adMare news
Vancouver Innovation Centre
2405 Wesbrook Mall
Vancouver, British Columbia, Canada
V6T 1Z3
T. 604.827.1147
Toronto Office
MaRS Centre, West Tower
661 University Ave., Suite 405
Toronto, Ontario, Canada
M5G 1M1
T. 416.673.8100
Montreal Innovation Centre
7171 Frederick-Banting
Montréal, Québec, Canada
H4S 1Z9
